CMS Open Payments · Program Year 2024
Endovascular Engineering Inc.
Endovascular Engineering Inc. reported $1,364,350.32 across General Payments, Research, and Ownership to 71 physicians and teaching hospitals across 72 transactions.
- $1.4M Above-median payer
- All-tracks total
- 72 Below-median volume
- Transactions
- 71 Below-median reach
- Recipients
- #542
- of 1,925 companies
Endovascular Engineering Inc. reported $1,364,350.32 across all CMS Open Payments tracks (General + Research + Ownership) to 71 physicians and teaching hospitals in Program Year 2024 - ranking #542 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $44,300.32, averaging $19.2K per recipient.
How Endovascular Engineering Inc.'s $1.4M all-tracks total breaks down
Endovascular Engineering Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
20/100
Total payments
F
23/100
Transaction volume
F
10/100
Physician reach
F
11/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer endovascular-engineering-inc Endovascular Engineering Inc.
$1.4M · #542/1,925 · 0.0% industry · PY2024
- TOT $1.4M
- RANK #542
- SHARE 0.0%
- TXN 72
- RCP 71
- CAT 3
- GEN $44.3K
- TOP1 32.1%
- PY 2024
Volume peers
Nearest volume peer: IGI Inc ($1.4M)
Endovascular Engineering Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Endovascular Engineering Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Endovascular Engineering Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
12 transactions worth $42.3K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 95.6% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Endovascular Engineering Inc. made 3 types of general payments. "Consulting Fee" is the largest category at $42.3K, 95.6% of General Payments.
How Endovascular Engineering Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $42.3K | 12 | 95.6% |
| Food and Beverage | $1.7K | 55 | 3.8% |
| Travel and Lodging | $272.60 | 4 | 0.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $39,565.00 (89.3%) of $44,300.32 in this company's General Payments records across 35 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Endovascular Engineering Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Delray Medical Center
$14,215.00 across 4 reported transactions
- 2
Huntington Hospital
$12,000.00 across 1 reported transactions
- 3
Karlyn Anne Martin
$8,500.00 across 1 reported transactions
- 4
Julie C Bulman
$2,500.00 across 1 reported transactions
- 5
Kendrick Shunk
$2,350.00 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Endovascular Engineering Inc.'s spend rank (#542 of 1,925, top 28% by spend) and concentration rank (#716 of 1,838, top 39% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Catalyst OrthoScience : $619.0K total payments, HHI 2229
- CorMedix Inc. : $120.2K total payments, HHI 2228
- Peter Brasseler Holdings, LLC : $2.8M total payments, HHI 2223
- Paragonix Technologies, Inc. : $2.6M total payments, HHI 2220
- Freudenberg Medical, LLC : $88.80 total payments, HHI 2216
- Servier BioInnovation : $2.1K total payments, HHI 2211
- Endovascular Engineering Inc. (this company) : $44.3K total payments, HHI 2208
- Body Vision Medical Inc. : $17.5K total payments, HHI 2201
- Zevra Therapeutics Inc : $34.8K total payments, HHI 2200
- Prexion, Inc. : $31.5K total payments, HHI 2195
- HT Medical, LLC : $28.7K total payments, HHI 2191
- Endogastric Solutions, Inc : $196.7K total payments, HHI 2176
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Endovascular Engineering Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Endovascular Engineering Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Endovascular Engineering Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Neurent Medical Limited
Agile Devices, Inc.
Vilex LLC
Trillium Therapeutics USA, LLC
Djo, LLC
Put this to use
Endovascular Engineering Inc. ranks #542 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Endovascular Engineering Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Endovascular Engineering Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.